PPB - Services

Complaints, Feedback and Enquiry

Medicine Quality Alert: Class II Medicine Recall of Neuropower Forte Batch Number 299 and 300

Essaar (K) Ltd has initiated a voluntary recall of Neuropower Forte tablets Batch Number 299 and 300.

From: Pharmacy and Poisons Board

Published: 9th September 2024

Recall Reference Number: REC/2024/022

Recall Classification: Class II

Recall Level: Retail level

Local Technical Representative: Essaar (K) Ltd

Manufacturer: Hof Pharmaceuticals Ltd

Product name: Neuropower Forte

Active Pharmaceutical Ingredient: Thiamine Mononitrate BP (vitamin B1) 10 mg, Riboflavin BP (Vitamin B2) 10 mg, Pyridoxine Hydrochloride BP 3 mg(Vitamin B6), Cyanocobalamin BP (VitaminB12) 15 mg, Nicotinamide BP 45 mg, Calcium Pantothenate BP 50 mg

Affected counties: All

Affected Batch

Batch Number

Date of Manufacture

Date of expiry

Pack Size

299

05/2023

04/2025

30’s

300

05/2023

04/2025

30’s

Brief description of the problem

The product is being recalled following market complaints of powdering/crumbling of tablets. Further investigation of the complaint sample at the PPB QC lab revealed that the tablets were moist, friable, and exhibited signs of degradation.

Action for healthcare professionals

Quarantine all the remaining stock and stop further distribution, sale, issuing, or use of the batch immediately. Await contact from Essaar (K) Ltd to arrange the return.

Action for patients and members of the public

Patients and members of the public who have the product batch are advised to immediately return the product to the nearest healthcare facility. Patients should continue taking other batches of the product other than the impacted batch and as prescribed by the healthcare professional.

Further Information

For inquiries about consignments of the impacted batch, please contact Essaar (K) Ltd at: gwangasa@gmail.com, neshat78@gmail.com, or Phone: +254 716 585 494 or +254 739 360 951.

You are advised to promptly report any case(s) of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:

For any further inquiries and feedback on the product recall, kindly contact the Post-Marketing Surveillance unit of The Pharmacy and Poisons Board Kenya via email at pms@ppb.go.ke.

Download document

Medicine Quality Alert: Class II Medicine Recall of Neuropower Forte Batch Number 299 and 300